SCHEMBL9175958

SCHEMBL9175958

CS(=O)(=O)Nc1cccc(CC(N)C(=O)OC(=O)OCc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 1/20 0.46
▸ TOP2B Q02880 1/20 0.46
▸ RAB9A P51151 2/20 0.44
▸ DRD2 P14416 1/20 0.43
▸ DRD4 P21917 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ NR3C1 P04150 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ AR P10275 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NOS3 P29474 1/20 0.42
▸ NOS1 P29475 1/20 0.42
▸ NOS2 P35228 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GHSR Q92847 2/20 0.42
▸ POLB P06746 1/20 0.41
▸ CTSD P07339 1/20 0.41
▸ SLC7A5 Q01650 2/20 0.40
▸ TACR1 P25103 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9437459 0.82 ALDH1A1 (0.48) DRD2DRD4DRD3NR3C1SMN1; SMN2
SCHEMBL9437458 0.82 ALDH1A1 (0.48) DRD2DRD4DRD3NR3C1SMN1; SMN2
SCHEMBL31689432 0.81 NOS3 (0.61) NR3C1SMN1; SMN2NOS3NOS1NOS2
SCHEMBL2367201 0.80 RAB9A (0.47) TOP2ATOP2BRAB9ANOS3NOS1
SCHEMBL3985411 0.79 SLC7A5 (0.56) ALDH1A1SLC7A5
SCHEMBL7330756 0.77 ITGB3 (0.57) ALDH1A1TACR1
SCHEMBL7330763 0.77 ITGB3 (0.57) ALDH1A1TACR1
SCHEMBL13542850 0.76 TOP2A (0.57) TOP2ATOP2BRAB9ADRD2DRD4
SCHEMBL28391235 0.76 SLC7A5 (0.57) ALDH1A1SLC7A5
SCHEMBL10694411 0.76 SLC7A5 (0.57) ALDH1A1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0658169-A1 DIAMINO ACID DERIVATIVES AS ANTIHYPERTENSIVES SCHERING CORPORATION (US) 1995-06-21 — — EP disclosed
Send feedback